Concepedia

Publication | Open Access

The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma

DOIFull Paper Access

86

Citations

59

References

2014

Year

Rocío Montes de, Zachary A. Gurard‐Levin, Frédérique Berger, Haniya Rehman, Elise Martel, Armelle Corpet, Leanne de Koning, Isabelle Vassias, Didier Meseure, Fabien Reyal,
Molecular Oncology

Abstract

The integration of chromatin regulators as clinical biomarkers, in particular the histone chaperone HJURP, will help guide patient substratification and treatment options for low-risk luminal A breast carcinoma patients.

References

YearCitations

Page 1